Breaking News

You are here » Indian-Commodity  :  Corporate  :  Suven Life Sciences secures product patents in New Zealand, Sri Lanka

14-Sep2018

Suven Life Sciences secures product patents in New Zealand, Sri Lanka

Suven Life Sciences has secured one product patent from New Zealand and one product patent from Sri Lanka corresponding to the New Chemical Entity for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2034 and 2031 respectively.

The granted claims of the patents include the class of selective 5-HT4 and H3 compounds respectively and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia and sleep disorders like Narcolepsy etc.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.


Related News

View all news

Sun Pharma reports consolidated net loss of Rs 219 crore in Q2

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2018.The company has reported net loss of Rs 906.42 crore for the quarter under review, as against net profit of......

Allahabad Bank planning to raise additional Rs 1,800-1,900 crore

Allahabad Bank is planning to raise additional Rs 1,800-1,900 crore to shore up capital adequacy. The Bank is exploring all options - government help, QIP, and hiving off non-core assets and stake in JVs.Allahabad......

RITES to acquire 33% stake in IRSDC

RITES has received in principle approval to acquire stake of 33% Equity Shares in Indian Railway Station Development Corporation (IRSDC). The Board of Directors of the company at their meeting held on......

Top News

View all news

RITES to acquire 33% stake in IRSDC

RITES has received in principle approval to acquire stake of 33% Equity Shares in Indian Railway Station Development Corporation (IRSDC). The Board of Directors of the company at their meeting held on......

Govt in favour of alignment of capital adequacy norms with Basel III norms

Instead of present stricter guidelines which restrict the lending capacity of lenders, the government is of the view that the Reserve Bank of India (RBI) should resort to Basel III norms for capital adequacy......

Infosys, Ashok Leyland and Reliance Infrastructure to see some action today

Infosys will open its next Technology and Innovation Hub in the State of Texas and hire 500 American workers in the state by 2020. The Hub will be located in Richardson, Texas and have a special focus......